$31.51
+1.16
(+3.82%)▲
Revenue is up for the last 6 quarters, 574.47M → 699.10M (in $), with an average increase of 3.8% per quarter
Netprofit is down for the last 2 quarters, -5.98M → -190.94M (in $), with an average decrease of 3089.3% per quarter
In the last 1 year, Fresenius Medical Care Ag & Co. Kgaa has given 53.4% return, outperforming this stock by 121.8%
4.28%
Downside
Day's Volatility :6.31%
Upside
2.11%
16.85%
Downside
52 Weeks Volatility :76.92%
Upside
72.25%
Period | Modivcare Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -32.21% | -3.0% | 0.0% |
6 Months | -62.88% | -0.6% | -1.9% |
1 Year | -67.94% | 6.3% | 6.3% |
3 Years | -80.64% | 22.5% | 15.5% |
Market Capitalization | 430.4M |
Book Value | $11.38 |
Dividend Share | 0.0 |
Dividend Yield | 2.38% |
Earnings Per Share (EPS) | -14.59 |
PEG Ratio | 1.44 |
Wall Street Target Price | 74.17 |
Profit Margin | -8.65% |
Operating Margin TTM | 1.7% |
Return On Assets TTM | 1.47% |
Return On Equity TTM | -84.79% |
Revenue TTM | 2.7B |
Revenue Per Share TTM | 188.53 |
Quarterly Revenue Growth YOY | 11.3% |
Gross Profit TTM | 472.3M |
EBITDA | 147.9M |
Diluted Eps TTM | -14.59 |
Quarterly Earnings Growth YOY | -0.75 |
EPS Estimate Current Year | 5.58 |
EPS Estimate Next Year | 7.07 |
EPS Estimate Current Quarter | 1.62 |
EPS Estimate Next Quarter | 1.9 |
What analysts predicted
Upside of 135.39%
FY17 | Y/Y Change | |
---|---|---|
Revenue | 1.6B | ↑ 2.85% |
Net Income | 53.4M | ↓ 41.94% |
Net Profit Margin | 3.29% | ↓ 2.53% |
FY18 | Y/Y Change | |
---|---|---|
Revenue | 1.4B | ↓ 14.71% |
Net Income | -19.0M | ↓ 135.57% |
Net Profit Margin | -1.37% | ↓ 4.66% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 1.5B | ↑ 9.02% |
Net Income | 966.0K | ↓ 105.09% |
Net Profit Margin | 0.06% | ↑ 1.43% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 1.4B | ↓ 9.36% |
Net Income | 88.8M | ↑ 9096.27% |
Net Profit Margin | 6.49% | ↑ 6.43% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 2.0B | ↑ 45.9% |
Net Income | -6.6M | ↓ 107.41% |
Net Profit Margin | -0.33% | ↓ 6.82% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 2.5B | ↑ 25.41% |
Net Income | -31.8M | ↑ 383.01% |
Net Profit Margin | -1.27% | ↓ 0.94% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Revenue | 574.5M | ↓ 0.23% |
Net Income | 318.0K | ↓ 101.01% |
Net Profit Margin | 0.06% | ↑ 5.54% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 628.2M | ↑ 9.35% |
Net Income | 3.3M | ↑ 946.54% |
Net Profit Margin | 0.53% | ↑ 0.47% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 647.8M | ↑ 3.11% |
Net Income | -28.5M | ↓ 956.52% |
Net Profit Margin | -4.4% | ↓ 4.93% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 653.9M | ↑ 0.95% |
Net Income | -6.9M | ↓ 75.63% |
Net Profit Margin | -1.06% | ↑ 3.34% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 662.3M | ↑ 1.28% |
Net Income | -6.0M | ↓ 13.82% |
Net Profit Margin | -0.9% | ↑ 0.16% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 699.1M | ↑ 5.56% |
Net Income | -190.9M | ↑ 3089.31% |
Net Profit Margin | -27.31% | ↓ 26.41% |
FY17 | Y/Y Change | |
---|---|---|
Total Assets | 704.1M | ↑ 1.4% |
Total Liabilities | 290.5M | ↓ 8.97% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 572.2M | ↓ 18.73% |
Total Liabilities | 183.9M | ↓ 36.72% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 597.4M | ↑ 4.39% |
Total Liabilities | 202.7M | ↑ 10.23% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 1.4B | ↑ 138.69% |
Total Liabilities | 1.0B | ↑ 400.47% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 2.0B | ↑ 42.18% |
Total Liabilities | 1.7B | ↑ 63.08% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 1.9B | ↓ 4.1% |
Total Liabilities | 1.6B | ↓ 3.9% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 2.1B | ↑ 4.22% |
Total Liabilities | 1.7B | ↑ 5.0% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 2.1B | ↓ 2.53% |
Total Liabilities | 1.7B | ↓ 3.41% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 2.0B | ↓ 3.39% |
Total Liabilities | 1.6B | ↓ 2.5% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.9B | ↓ 2.29% |
Total Liabilities | 1.6B | ↓ 2.81% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.9B | ↓ 0.14% |
Total Liabilities | 1.6B | ↑ 0.04% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.8B | ↓ 8.06% |
Total Liabilities | 1.6B | ↑ 2.08% |
FY17 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 55.0M | ↑ 32.69% |
Investing Cash Flow | 814.0K | ↓ 99.75% |
Financing Cash Flow | -33.8M | ↓ 91.03% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 7.9M | ↓ 85.65% |
Investing Cash Flow | -45.3M | ↓ 5667.81% |
Financing Cash Flow | -51.6M | ↑ 52.58% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 60.9M | ↑ 671.49% |
Investing Cash Flow | -10.9M | ↓ 76.04% |
Financing Cash Flow | -776.0K | ↓ 98.49% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 348.4M | ↑ 471.77% |
Investing Cash Flow | -635.0M | ↑ 5748.33% |
Financing Cash Flow | 408.3M | ↓ 52710.82% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 186.8M | ↓ 46.38% |
Investing Cash Flow | -685.6M | ↑ 7.97% |
Financing Cash Flow | 448.9M | ↑ 9.94% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 69.1M | ↑ 468.66% |
Investing Cash Flow | -8.6M | ↑ 88.87% |
Financing Cash Flow | 566.0K | ↓ 164.98% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -17.9M | ↓ 125.86% |
Investing Cash Flow | -86.2M | ↑ 903.91% |
Financing Cash Flow | -2.5M | ↓ 532.86% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -5.7M | ↓ 68.2% |
Investing Cash Flow | -9.6M | ↓ 88.83% |
Financing Cash Flow | 57.0K | ↓ 102.33% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -2.7M | ↓ 95.26% |
Investing Cash Flow | -13.3M | - |
Financing Cash Flow | 14.4M | ↑ 155.19% |
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Modivcare Inc | -2.81% | -62.88% | -67.94% | -80.64% | -80.64% |
![]() Fresenius Medical Care Ag & Co. Kgaa | -9.42% | 0.0% | 51.48% | -48.54% | -59.22% |
![]() Hca Holdings, Inc. | -12.4% | -6.88% | 27.28% | 97.48% | 75.32% |
![]() Universal Health Services Inc. | -6.57% | -1.53% | 35.66% | 18.39% | -2.3% |
![]() Davita Healthcare Partners Inc. | -8.21% | 15.72% | 9.4% | 14.14% | 27.67% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Modivcare Inc | NA | NA | 1.44 | 5.58 | -0.85 | 0.01 | 0.02 | 11.38 |
![]() Fresenius Medical Care Ag & Co. Kgaa | 20.43 | 20.43 | 1.06 | 1.98 | 0.05 | 0.03 | 0.03 | 23.05 |
![]() Hca Holdings, Inc. | 12.38 | 12.38 | 1.37 | 18.44 | 0.21 | 0.11 | 0.01 | -8.44 |
![]() Universal Health Services Inc. | 13.17 | 13.17 | 1.87 | 10.19 | 0.11 | 0.05 | 0.01 | 87.72 |
![]() Davita Healthcare Partners Inc. | 18.98 | 18.98 | 0.86 | 7.21 | 0.29 | 0.05 | 0.0 | 11.15 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Modivcare Inc | Buy | $430.4M | -80.64% | NA | -8.65% |
![]() Fresenius Medical Care Ag & Co. Kgaa | Hold | $12.8B | -59.22% | 20.43 | 3.04% |
![]() Hca Holdings, Inc. | Buy | $68.2B | 75.32% | 12.38 | 9.32% |
![]() Universal Health Services Inc. | Hold | $8.8B | -2.3% | 13.17 | 5.02% |
![]() Davita Healthcare Partners Inc. | Hold | $8.6B | 27.67% | 18.98 | 3.98% |
BlackRock Inc
Coliseum Capital Management LLC
T. Rowe Price Investment Management,Inc.
Vanguard Group Inc
Fuller & Thaler Asset Management Inc
Neuberger Berman Group LLC
Modivcare Inc’s price-to-earnings ratio stands at None
Read Moremodivcare is a healthcare services leader. our company was created to address the social determinants of health (sdoh) by providing non-emergency medical transportation (nemt), personal care, nutritious meals, and remote patient monitoring. we provide integrated technologies that support care solutions for payors and their members – leading to greater access to care, reduced costs, and improved outcomes.
Organization | Modivcare Inc |
Employees | 20000 |
CEO | Mr. L. Heath Sampson |
Industry | Healthcare |
Dynavax Technologies Corporation
$31.51
+3.82%
Lemaitre Vascular Inc
$31.51
+3.82%
Collegium Pharmaceutical Inc
$31.51
+3.82%
Agios Pharmaceuticals, Inc.
$31.51
+3.82%
Eagle Pharmaceuticals Inc.
$31.51
+3.82%
Scilex Holding Co
$31.51
+3.82%
Bluebird Bio, Inc.
$31.51
+3.82%
Acorda Therapeutics, Inc.
$31.51
+3.82%
Mannkind Corp.
$31.51
+3.82%